Former CEO of California Stem Cell Agency Named to Board of Firm that Received $19 Million From the Agency
By David Jensen,
California Stem Cell Report
| 07. 07. 2014
Untitled Document
Alan Trounson, the former president of the $3 billion California stem cell agency, today was named to the board of a company that has
received $19.4 million from the agency, raising fresh and serious questions about conflicts of interest at the state-funded research program.
Announcement of the appointment came only seven days after Trounson left state employment. Trounson has been dogged for some time with questions about his relationship to the company,
StemCells, Inc., of Newark, Ca., and its co-founder, eminent
Stanford researcher
Irv Weissman, who sits on the company’s six-man board and is chairman of its scientific advisory board.
StemCells, Inc., announced Trounson’s appointment in
a press release this morning. The publicly traded firm said it was “thrilled” to have Trounson on its board. The first sentence of its press release noted that he had served as head of “the largest scientific funding body for stem cell research in the world.”
Weissman is director of the
Institute of Stem Cell Biology and Regenerative Medicine at Stanford. He has
received $34.7 million from the agency...
Related Articles
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
